Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06869512 · ClinicalTrials.gov registry record · NA
Cooperative Extension and Cancer Survivorship
A NA study of Cancer Survivorship, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06869512: Recruiting NA study of Cancer Survivorship, sponsored by University of Oklahoma.
NCT06869512 is a NA study of Cancer Survivorship that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 80 participants, below the 254-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06869512, a NA study of Cancer Survivorship, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment. Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS will be feasible and acceptable as evidenced by delivery of the intervention among Educators (implementation), including in agreement with the curriculum in Phase 1 (fidelity) with \>85% attendance (demand) among participants with \>80% rating the intervention as acceptable or highly acceptable on 5-point Likert-type scale (acceptability). Aim 2: Determine the preliminary efficacy of SUCCESS for improving HRQOL (primary outcome) and other psychosocial and health-related endpoints (e.g., financial toxicity) (secondary outcomes). Hypothesis 2: Compared to matched controls, adults LWBC who complete SUCCESS will have significant improvements in HRQOL per the PROMIS Global Health v1.2 at follow-up (i.e., after 6 weeks). Aim 3: Examine changes in conserved transcriptional response to adversity (CTRA) gene expression in a subset of interventions participants at follow-up. Hypothesis 3: Adults LWBC who complete SUCCESS will experience significant CTRA down-regulation. This is a single arm trial and there is no comparison group. Participants will be asked to do survey- and Zoom-based data collection before and after completing the 6-week program.
Primary Outcome
We will measure the percent of SUCCESS sessions delivered as planned by Educators
Conditions Studied
Interventions
- BEHAVIORAL SUCCESS
Study Locations (1)
Oklahoma
- University of Oklahoma - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06869512 shows while recruiting
NCT06869512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 254-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Cancer Survivorship appearing as the primary indexed condition, and to 1 intervention - of which SUCCESS is the first listed.
NCT06869512 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06869512 about?
NCT06869512 is a clinical study titled "Cooperative Extension and Cancer Survivorship". The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment. Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS wil...
What is the current status of trial NCT06869512?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-02-24. Estimated completion is 2026-12-31.
What conditions does trial NCT06869512 study?
This clinical trial studies the following conditions: Cancer Survivorship.
What interventions are being tested in trial NCT06869512?
The interventions under investigation include: SUCCESS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06869512?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06869512 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Survivorship
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06869512's enrollment target sits among peer trials
80 7th of 11 higher than 4 of 11 other Cancer Survivorship trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
RECRUITING · NA
-
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI